Mapping human brain development: Insights into neural differentiation and disease risk

Medicover Genetics Editorial Team|

Scientifically checkedView our editorial guidelines
Scientifically checked

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study offers a detailed map of this process, tracking how different brain regions and cell types evolve from the first trimester through adolescence. The researchers identified a new type of progenitor cell—Tri-IPCs—that plays a critical role in generating both neurons and glial cells. Interestingly, glioblastoma cells share key characteristics with these progenitors, raising the possibility that cancer may exploit normal developmental pathways. The study also connects specific brain cell types to autism risk, offering valuable insights into neurodevelopmental disorders. These findings deepen our understanding of brain development and its links to disease. Read more about this under Article 1 below.

Article 1: Molecular and cellular dynamics of the developing human neocortex

A new atlas of human neocortex development identifies gene networks that drive neural differentiation at five key stages. Key takeaways include the identification of Tri-IPCs as progenitors of diverse brain cells and their similarity to glioblastoma cells, as well as a link between second-trimester neurons and autism risk. This resource offers critical insights into neurodevelopment and its relevance to disease. Read the full article .

In summary: Gene networks guide brain development and influence autism risk

Article 2: Brain change trajectories in healthy adults correlate with Alzheimer’s related genetic variation and memory decline across life

A study of adults aged 30-89 reveals that genetic risk for Alzheimer’s accelerates brain loss in regions sensitive to the disease and correlates with memory decline. Machine learning models have pinpointed early neurodegeneration patterns, showing that most individuals over age 50 follow an accelerated aging trajectory linked to genetic Alzheimer’s risk. Read the full article .

In summary: Alzheimer’s genes contribute to faster brain aging and memory decline

Article 3: Complex rearrangements fuel ER+ and HER2+ breast tumours

An analysis of 1,828 breast tumours identifies three distinct genomic patterns that influence tumour evolution, immune interaction, and therapeutic response. High-risk ER+ subtypes exhibit complex amplifications, such as HER2+ tumours, while triple-negative tumours show widespread genome instability. These early-established patterns persist in metastasis, offering insights into potential targeted therapies for improved clinical outcomes. Read the full article .

In summary: Genomic changes drive breast cancer evolution and treatment strategies

Article 4: Clinical evaluation of long-read sequencing-based episignature detection in developmental disorders

A recent study demonstrates that nanopore sequencing can detect episignatures linked to developmental disorders, with results consistent with microarray testing. A machine-learning classifier identified these episignatures in 17 of 19 patients with pathogenic variants. The sequencing also uncovered genetic variants, X-inactivation patterns, and imprinting errors, consolidating multiple diagnostic steps into one comprehensive test. Read the full article .

In summary: Nanopore sequencing identifies developmental disorder markers and genetic variants

Last updated: 11.09.2026

Latest articles

All about genetics
Health and well-being
Hereditary diseases
  • VERACITY

    New-generation non-invasive prenatal screening from week 9 of pregnancy, analysing fetal cell-free DNA in maternal blood to detect selected chromosomal abnormalities with high sensitivity and specificity for early and reliable prenatal risk assessment.

  • Pharmacogenomics

    Enabling personalised treatments for safer, more effective care through genetic insights that guide optimal prescribing from the start and refine therapy when patients experience side effects or poor response.

  • ebiom+

    A comprehensive assessment of the endometrial microbiome and chronic endometritis pathogens to enhance clinical outcomes, prevent treatment delays, and support a more informed, personalised fertility care.

  • WES

    Advanced sequencing that simultaneously analyses a broad range of genes to detect the genetic basis of complex diseases, improve diagnostic accuracy, and inform recurrence risk assessment for better clinical decision-making.

Why Medicover Genetics

Leader in genetic testing with >25 years of experience in counselling and diagnostics

Comprehensive CE-IVD kit portfolio and seamless Technology Transfer solution for laboratories of any size

End-to-end clinical workflow from sample processing to sequencing analysis and reporting

CAP- and CLIA- and ISO15189 accredited, GMP- and ISO9001 and 13485 certified

Are you a patient?

Are you a physician?